학술논문
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
Document Type
Article
Author
Huber, Henriette; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Zhang, Can; Tausch, Eugen; Schneider, Christof; Bloehdorn, Johannes; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna L.; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
Source
In Blood 3 March 2022 139(9):1318-1329
Subject
Language
ISSN
0006-4971